A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Conditions
Acute Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Phoenix, Goodyear, Arizona, United States
City of Hope, Duarte, California, United States
University of California Irvine Medical Center, Orange, California, United States
University of California San Francisco, San Francisco, California, United States
UCSF Benioff Children's Hospital, San Francisco, California, United States
University of Chicago, Chicago, Illinois, United States
St Francis Hospital & Health Centers Indiana Blood and Marrow Transplantation, Indianapolis, Indiana, United States
Norton Cancer Institute, Louisville, Kentucky, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Start Midwest, Grand Rapids, Michigan, United States
University of New Mexico, Albuquerque, New Mexico, United States
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
NYU Langone Medical Center, New York, New York, United States
Montefiore Medical Center, The Bronx, New York, United States
Oregon Health And Science University, Portland, Oregon, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Maine Health, Providence, Rhode Island, United States
University of Tennessee Medical Center, Knoxville, Tennessee, United States
Baylor University Medical Center, Dallas, Texas, United States
Houston Methodist Hospital, Houston, Texas, United States
MD Anderson, Houston, Texas, United States
San Antonio Methodist TX Transplant Physicians Group, San Antonio, Texas, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Swedish Cancer Institute, Seattle, Washington, United States
Medical College of WI at Froedtert, Milwaukee, Wisconsin, United States
Monash Medical Centre, Clayton, Australia
Royal Perth Hospital, Perth, Australia
Gold Coast University Hospital, Southport, Australia
Ghent University Hospital, Ghent, Belgium
Instituto D Or de Pesquisa e Ensino, Brasília, Brazil
Liga Norte Riograndense Contra O Cancer, Natal, Brazil
Ministerio da Saude Instituto Nacional do Cancer, Rio de Janeiro, Brazil
Fundacao Faculdade de Medicina Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil
Instituto D Or de Pesquisa e Ensino IDOR, São Paulo, Brazil
Fundacao Antonio Prudente A C Camargo Cancer Center, São Paulo, Brazil
Vancouver Coastal Health, Vancouver, British Columbia, Canada
Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada
Hopital Maisonneuve Rosemont, Montreal, Quebec, Canada
Peking University First Hospital, Beijing, China
The First Hospital of Jilin University, Changchun, China
West China Hospital Si Chuan University, Chengdu, China
Nanfang Hospital of Southern Medical Hospital, Guangzhou, China
First Affiliated Hospital Medical School of Zhejiang University, Hangzhou, China
Qilu Hospital of Shandong University, Jinan, China
The First Affiliated Hospital of NanChang University, Nanchang, China
Zhongda Hospital Southeast University, Nanjing, China
Institute of Hematology and Blood Diseases Hospital, Tianjin, China
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Union Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
Henan Cancer Hospital, Zhengzhou, China
Hopital Jean Minjoz, Besançon, France
Institut Paoli Calmettes, Marseille, France
CHU de Nantes hotel Dieu, Nantes, France
Hopital Saint Louis, Paris, France
Hopital trousseau- APHP, Paris, France
Centre Hospitalier Universitaire (CHU) de Bordeaux Hopital HautLeveque Centre Francois Magendie, Pessac, France
CHU Lyon Sud, Pierre-Bénite, France
Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre, Strasbourg, France
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
CHU Bretonneau, Tours, France
CHRU de Nancy - Hopitaux de Brabois, Vandœuvre-lès-Nancy, France
CHRU Nancy Brabois, Vandœuvre-lès-Nancy, France
Gustave Roussy, Villejuif, France
Carmel Medical Center, Haifa, Israel
Hadassah University Hospita Ein Kerem, Jerusalem, Israel
Sheba Medical Center, Ramat Gan, Israel
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Kyushu University Hospital, Fukuoka, Japan
Fukushima Medical University Hospital, Fukushima, Japan
Kanazawa University Hospital, Kanazawa, Japan
National Cancer Center Hospital East, Kashiwa, Japan
Kobe City Medical Center General Hospital, Kobe, Japan
Gunmaken Saiseikai Maebashi Hospital, Maebashi, Japan
Nagoya University Hospital, Nagoya, Japan
Hokkaido University Hospital, Sapporo, Japan
NTT Medical Center Tokyo, Tokyo, Japan
Yamagata University Hospital, Yamagata, Japan
University of Fukui Hospital, Yoshida, Japan
Seoul National University Hospital, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Hosp Univ Vall D Hebron, Barcelona, Spain
Hosp Clinic de Barcelona, Barcelona, Spain
Hosp. Gral. Univ. Gregorio Maranon, Madrid, Spain
Hospital Infantil Universitario Nino Jesus, Madrid, Spain
Hosp Univ Fund Jimenez Diaz, Madrid, Spain
Clinica Univ. de Navarra, Pamplona, Spain
Hosp Clinico Univ de Salamanca, Salamanca, Spain
Hosp. Virgen Del Rocio, Seville, Spain
Hosp. Clinico Univ. de Valencia, Valencia, Spain
China Medical University Hospital, Taichung, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
University Hospital of Wales, Cardiff, United Kingdom
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
The Clatterbridge Cancer Centre, Liverpool, United Kingdom
Guys and St Thomas NHS Foundation Trust, London, United Kingdom
University College London Hospitals, London, United Kingdom
The Christie Nhs Foundation Trust, Manchester, United Kingdom
Oxford University Hospitals NHS Trust, Oxfordshire, United Kingdom
University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
Study leads
Janssen Research & Development, LLC Clinical Trial
Study Director
Janssen Research & Development, LLC